AMY RUIZ: Open Payments
NPI 1053060301 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,421 in 90 payments from 43 companies in 2025. Trend: 2023 $1,648 · 2024 $2,702 · 2025 $2,421
Food & beverage: $2,421
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 5 | $244 |
| AstraZeneca Pharmaceuticals LP | 6 | $180 |
| Myriad Genetic Laboratories, Inc. | 3 | $154 |
| Janssen Biotech, Inc. | 5 | $130 |
| GlaxoSmithKline, LLC. | 1 | $121 |
| Novartis Pharmaceuticals Corporation | 4 | $105 |
| Eisai Inc. | 4 | $101 |
| Daiichi Sankyo Inc. | 4 | $86 |
| BeOne Medicines USA, Inc. | 3 | $83 |
| ABBVIE INC. | 3 | $79 |
Products named: LIBTAYO, MYRISK, OJJAARA, Enhertu, Lenvima, KEYTRUDA, MONOFERRIC, BRUKINSA.
Industry payments across OH — which companies pay providers there.
